Differentiated Immunohistochemical Expression of Osteoclastogenic Markers in Radicular Cyst, Odontogenic Keratocyst, and Ameloblastoma

摘要

Abstract: The aim of this study was to investigate the osteoclasto-genesis process by means of immunohistochemical markers for receptor activator of nuclear factor κB ligand (RANKL), osteoprote-gerin (OPG), interleukin-6 (IL-6), and cathepsin K (CTSK) antigens in osteolytic lesions of maxillary bones. The sample consisted of 23 radicular cysts (RC), 25 odontogenic keratocysts (OKC), and 25 ameloblastomas (AM). RANKL was statistically higher in RC (49.6 ± 15.2/53.7 ± 18) and OKC (48.6 ± 15.1/51.4 ± 16.8) when compared with AM (37.2 ± 12.5/36.4 ± 13) in the epithelium and connective tissue. OPG was lower in OKC (34.8 ± 18.5) only in connective tissue when compared with RC (44.5 ±11.2). The expression of RANKL was statistically higher than OPG in RC (epithelium and connective tissue) and OKC (connective tissue). For IL-6, a statistical difference was observed only in the connective tissue between groups, with higher expression in RC (48.2 ±15) and lower in OKC (22 ± 11.9). The expression of IL-6 was correlated with the intensity of the inflammatory infiltrate. CTSK was statistically higher in AM (34 ±19) and OKC (29 ±13.8) compared with RC (19 ±10.5). According to the results of the present research the bone resorption in cysts and odontogenic tumors occurs through different mechanisms. The ostoclastogenic process in lesions with aggressive clinical behavior, as AM and OKC, seems to be associated with the expression of CTSK. Tn contrast, lesions with inflammatory etiology, as RC, the expression of IL-6 seems to have an important role in the bone resorption process. The highest expression of RANKL under the expression of OPG also seems to contribute to the growth mechanism of RC and OKC.